IV Bags, Nexterone Amiodarone HCI 150 mg Premixed Injection 100 mL x 12/Case (RX)
How to Order:
You will receive instructions on how to create an account along with Rx Ordering Details.
(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Nexterone is a brand name for a form of the drug amiodarone, which is an antiarrhythmic medication used primarily to treat and prevent various types of serious irregular heartbeats (arrhythmias), including ventricular fibrillation and ventricular tachycardia. The "HCl" stands for hydrochloride, indicating the salt form of amiodarone.
The 150 mg premixed injection IV bags contain amiodarone in a ready-to-use format for intravenous (IV) administration, typically prepared in a 100 mL solution. This can be particularly beneficial in acute settings, such as during a cardiac arrest or severe arrhythmias, since it provides healthcare providers with a convenient and sterile option for delivering the medication.
Nexterone is designed to be administered in a hospital setting, where medical professionals can closely monitor patients for efficacy and any potential side effects. Common side effects of amiodarone include hypotension, bradycardia, and potential lung or liver toxicity with long-term use. As with all medications, the use of Nexterone should be guided by a healthcare professional, considering the specific clinical context and patient needs.
Nexterone (amiodarone hydrochloride) is an antiarrhythmic medication primarily used to treat various types of serious ventricular and atrial arrhythmias. The mechanism of action of amiodarone is complex and involves multiple pathways. Here are the key mechanisms through which it exerts its effects:
Sodium Channel Blockade: Amiodarone inhibits sodium channels, which slows down the conduction of electrical impulses in the heart. This helps to stabilize the cardiac rhythm and reduce the occurrence of arrhythmias.
Potassium Channel Blockade: It prolongs the action potential duration and refractory period in cardiac tissues by blocking potassium channels. This is particularly important in preventing reentrant tachycardias and helps to correct abnormal rhythms.
Calcium Channel Blockade: Amiodarone has mild calcium channel-blocking properties, which can decrease the contractility of the heart and slow down the heart rate.
Beta-Adrenergic Blocking Activity: Amiodarone exhibits some non-selective beta-adrenergic antagonism, which can further contribute to its antiarrhythmic effects by decreasing heart rate and myocardial oxygen demand.
Impact on Thyroid Hormone Metabolism**: Amiodarone has structural similarities to thyroid hormones and can influence thyroid function. This is particularly relevant because changes in thyroid hormone levels can affect cardiac rhythm.
Vasodilation: Amiodarone may also cause vasodilation, which can help reduce the workload of the heart and improve coronary blood flow.
By acting through these various mechanisms, amiodarone is effective in managing a wide range of arrhythmias, including atrial fibrillation and ventricular tachycardia. It is important to note that the medication's action can be quite prolonged, with effects lasting days to weeks after discontinuation due to its long half-life and accumulation in body tissues. This multi-faceted approach makes amiodarone a versatile agent in the management of arrhythmic conditions.
